Regulatory Approval

AM Best affirms Fairfax's 'Excellent' rating after a year of record profits and major catastrophes. We deconstruct the strategy behind this financial paradox.

A new Guinness World Record for a plug-in hybrid isn't just a number. It's a strategic shot across the bow, challenging EV dominance and redefining mobility.

In nine years, Wellington-Altus hit $50B AUA and a 7th top-dealer award. It's more than growth; it’s a strategic coup for advisor independence.

A new partnership uses healthcare data expertise to guide military caregivers through a mental health crisis. But is this innovative solution enough?

Canada injects $600M into its cultural sector while ordering a rethink of streaming rules, pitting consumer affordability against a landmark digital policy.

As insurtech giants like Duck Creek roll out 'agentic' AI, the race is on. But scaling this powerful technology hinges on a non-negotiable factor: trust.

MiniMed and Abbott are partnering on a dual glucose-ketone sensor, a move that could shift diabetes care from crisis management to proactive DKA prevention.

A landmark dual certification for 2,200 Indonesian smallholders isn't just an eco-win; it's a strategic masterclass in navigating global headwinds.

Precision Cardiovascular adds serial entrepreneur Brian Fahey to its board, signaling a push to commercialize its implantable SAW sensor and AI platform.

A new partnership embeds quantum-resilient security into AI robotics, signaling a strategic maneuver to preempt future threats and dominate a new era of compliance.

A recent FDA approval for a generic cancer drug adds to a growing market, revealing the strategic alliances redefining healthcare access.

With CE Mark approval for its SOUND REACH Swift, Genesis MedTech brings a 'plug-and-play' ultrasonic shear to Europe, promising to simplify complex open surgeries.

Cell therapies promise miracles, but a decades-old test for cell health is flawed. A new global standard aims to bring much-needed precision and safety.

FDA clearance for Pulmera's CBeam platform could democratize surgery by turning standard 2D X-ray machines into advanced 3D imagers, slashing costs.

With AI poised to dominate enterprise communication, a startup's $10M seed round bets its 'pre-send' firewall can solve a $2.2 billion regulatory headache.

A biometric breakthrough promises to solve crimes faster than ever. But as AI closes cold cases, it opens a Pandora's box of ethical and privacy questions.

With a key promotion and hires specializing in digital assets and niche liquidity, Wedbush is betting on talent and tech to win the future of equity trading.

Quoin Pharmaceuticals files the first-ever drug application for Peeling Skin Syndrome, offering a glimmer of hope for patients with no treatment options.

Lockton and Nexar's new AV safety standard uses real-world data to finally answer the question: Are autonomous cars safer than us? The answer could unlock billions.

Sift's new FedRAMP High status, fast-tracked by Knox Systems, allows federal agencies to deploy its advanced sensor data analysis for mission-critical hardware.